DNAzyme and controllable cholesterol stacking DNA machine integrates dual-target recognition CTCs enable homogeneous liquid biopsy of breast cancer

Weijing Liu,Yue Wang,Pengjun Jiang,Ke Huang,He Zhang,Jie Chen,Piaopiao Chen

DOI: https://doi.org/10.1016/j.bios.2024.116493

IF: 12.545

2024-06-14

Biosensors and Bioelectronics

Abstract:Although circulating tumor cells (CTCs) have demonstrated considerable importance in liquid biopsy, their detection is limited by low concentrations and complex sample components. Herein, we developed a homogeneous, simple, and high-sensitivity strategy targeting qualifying breast cancer cells. This method was based on a non-immunological stepwise centrifugation preprocessing to isolate CTCs from whole blood. Achieving precise quantification relied on the specific binding of aptamers to the overexpressed mucin 1 (MUC1) and human epidermal growth factor receptor 2 (HER2) proteins of breast cancer cells. Subsequently, DNAzyme cleavage and parallel catalytic hairpin assembly (CHA) reactions on the cholesterol-stacking DNA machine were initiated, which opened the hairpin structures T-Hg 2+ -T and C-Ag + -C as well as enabled multiple amplifications. This leads to the fluorescence signal reduction from Hg 2+ -specific carbon dots (CDs) and CdTe quantum dots (QDs) by released ions. This strategy demonstrated a detection performance with a limit of detection (LOD) of 3 cells/mL and a linear range of 5-100 cells/mL. 42 clinical samples have been validated, confirming their consistency with clinical imaging, pathology findings and the folate receptor (FR)-PCR kit results, exhibiting desirable specificity of 100% and sensitivity of 80.6%. These results highlight the promising applicability of our method for diagnosing and monitoring breast cancer.

biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology